We are live on
!
Find out more
VHAM
Van Hulzen Asset Management Portfolio holdings
AUM
$1.35B
1-Year Est. Return
22.73%
This Fund
S&P 500
This Quarter
Est. Return
-12.11%
1 Year Est. Return
+22.73%
3 Year Est. Return
+75.53%
5 Year Est. Return
+93.64%
10 Year Est. Return
+300.03%
AUM
$837M
AUM Growth
-$106M
(-11%)
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
3.06%
Top 10 Holdings %
Top 10 Hldgs %
29.85%
Holding
333
New
25
Increased
125
Reduced
93
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$22.2M |
| 2 |
Qualcomm
QCOM
|
+$18.2M |
| 3 |
IBM
IBM
|
+$15.9M |
| 4 |
McDonald's
MCD
|
+$14.4M |
| 5 |
Eaton
ETN
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$19.2M |
| 2 |
Intercontinental Exchange
ICE
|
+$18.2M |
| 3 |
Altria Group
MO
|
+$16.4M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$15.2M |
| 5 |
Darden Restaurants
DRI
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.99% |
| 2 | Healthcare | 12.44% |
| 3 | Consumer Staples | 8.15% |
| 4 | Communication Services | 7.14% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
BioNTech
BNTX
$23.5B
| $597K | 0.07% |
+4,001
| New | +$611K |
|
152
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $594K | 0.07% |
5,841
+915
| +19% | +$99.2K |
|
153
FirstCash
FCFS
$8.78B
| $593K | 0.07% |
8,533
+5,012
| +142% | +$361K |
|
154
Vanguard S&P 500 ETF
VOO
$1.01T
| $579K | 0.07% |
1,668
+2
| +0.1% | +$753 |
|
155
Bristol-Myers Squibb
BMY
$132B
| $558K | 0.07% |
7,246
-120
| -2% | -$9.14K |
|
156
Boeing
BA
$185B
| $551K | 0.07% |
4,028
+25
| +0.6% | +$3.69K |
|
157
Phillips 66
PSX
$81.4B
| $551K | 0.07% |
6,715
| – | – |
|
158
Intuit
INTU
$89B
| $545K | 0.07% |
1,413
| – | – |
|
159
Vanguard FTSE Developed Markets ETF
VEA
$236B
| $543K | 0.06% |
+13,301
| New | +$591K |
|
160
American Electric Power
AEP
$68.4B
| $542K | 0.06% |
5,651
+1,316
| +30% | +$130K |
|
161
Alphabet (Google) Class C
GOOG
$4.32T
| $540K | 0.06% |
4,940
+260
| +6% | +$30.7K |
|
162
Lockheed Martin
LMT
$136B
| $530K | 0.06% |
1,232
-182
| -13% | -$79.9K |
|
163
Upstart Holdings
UPST
$3.03B
| $530K | 0.06% |
16,758
+10,388
| +163% | +$619K |
|
164
Texas Roadhouse
TXRH
$13.7B
| $517K | 0.06% |
7,060
+176
| +3% | +$13.8K |
|
165
LeMaitre Vascular
LMAT
$1.86B
| $508K | 0.06% |
11,149
+223
| +2% | +$9.97K |
|
166
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $496K | 0.06% |
15,073
+1,974
| +15% | +$66.8K |
|
167
PNC Financial Services
PNC
$101B
| $494K | 0.06% |
3,128
+238
| +8% | +$39.9K |
|
168
iShares S&P 500 Growth ETF
IVW
$77.6B
| $490K | 0.06% |
8,113
-5
| -0.1% | -$331 |
|
169
First Horizon
FHN
$12.1B
| $479K | 0.06% |
21,900
| – | – |
|
170
Qualys
QLYS
$6.35B
| $476K | 0.06% |
3,777
-3,141
| -45% | -$411K |
|
171
iShares International Select Dividend ETF
IDV
$8.51B
| $475K | 0.06% |
17,480
+686
| +4% | +$20.7K |
|
172
Thermo Fisher Scientific
TMO
$220B
| $470K | 0.06% |
865
| – | – |
|
173
Dollar General
DG
$27.9B
| $458K | 0.05% |
1,865
-101
| -5% | -$23.6K |
|
|
VPU
174
Vanguard Utilities ETF
VPU
$8.36B
| $456K | 0.05% |
2,991
-86
| -3% | -$13.5K |
|
175
Gilead Sciences
GILD
$165B
| $454K | 0.05% |
7,340
+814
| +12% | +$50.4K |
|
Similar funds
HAM
ME
BFMH
4WM
MC
SEP
AWA
RCM
Van Hulzen Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Van Hulzen Asset Management held 333 positions worth $837M, down 11% from $943M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Van Hulzen Asset Management deployed $25.6M of net new capital in Q2 2022, opening 25 new positions and adding to 125 existing holdings. Its largest new stake was Walgreens Boots Alliance: 221,780 shares worth $8.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $19.2M trimmed.
- Van Hulzen Asset Management's largest Q2 2022 buy was Walgreens Boots Alliance: 221,780 shares worth $8.4M.
- Van Hulzen Asset Management added most to Johnson & Johnson in Q2 2022, an estimated $22.2M increase.
- Van Hulzen Asset Management's biggest Q2 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $19.2M.
- Van Hulzen Asset Management fully exited State Street Technology Select Sector SPDR ETF in Q2 2022, selling an estimated $15.2M.
- Van Hulzen Asset Management's ten largest holdings make up 30% of its $837M portfolio in Q2 2022.
- Van Hulzen Asset Management opened 25 new positions and closed 37 in Q2 2022.
- Van Hulzen Asset Management's portfolio value fell 11% quarter-over-quarter to $837M.
Based on Van Hulzen Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.